• Skip to main content
  • Skip to footer

Oklahoma Medical Research Foundation | OMRF

OMRF is an independent, nonprofit biomedical research institute dedicated to discoveries that make a difference.

  • About
    • General Information
    • Disease Research
    • Education & Outreach
    • Events
    • Careers
    • Contact Us
  • Science
    • Scientist Directory
    • Research Programs
    • Research Centers
    • Core Facilities
    • Scientific Publications
    • Scientific Seminars
    • Technology Ventures
  • News
    • Media Resources
    • News Releases
    • Publications
    • On Your Health
    • Bodywork
  • Patients
    • Anti-Aging Studies
    • Lupus (SLE)
    • MBTPS1 Related Disorders
    • Multiple Sclerosis
    • Rheumatoid Arthritis
    • Sarcoidosis
    • Sjögren’s Disease
    • Other Autoimmune Disorders
  • Donate
    • Donate Now
    • Tax Credit
    • Planned Giving
    • Vehicle Donations
    • Why We Give
    • Your Gift at Work
    • Donor Recognition
    • Contact
Home - OMRF News - Archives for option

option

New approach shows promise for arthritis relief

November 10, 2020

There are no approved treatments for osteoarthritis, which affects an estimated 50 million Americans.

Filed Under: News Tagged With: arthritis, Griffin, health, jeffries, matlock, new, news, newsok, oa, obesity, OKC, Oklahoma Medical Research Foundation, OMRF, option, osteoarthritis, scientist-news, stanford, surgery, Timothy, treatment

Searching for new arthritis treatments

April 24, 2019

Arthritis is the leading cause of disability in adults in the U.S. Understandably, this has led to much concern about the future of arthritis treatment.

Filed Under: News Tagged With: aging, arthritis, biomarkers, disability, drugs, elderly, Griffin, James, Judith, Judith James, newsok, oa, OKC, Oklahoma Medical Research Foundation, OMRF, option, osteoarthritis, ra, research, rheumatoid arthritis, science, scientist-news, study, therapeutic, therapy, Tim Griffin, Timothy, trauma, treatment

OMRF discovers potential therapy for age-related muscle loss

December 4, 2018

An OMRF discovery could potentially open the door for the first drug option to treat age-related muscle weakness and atrophy.

Filed Under: News Tagged With: age, aging, atrophy, cnd1163, diet, drug, exercise, experimental, healthy, Holly, Holly Van Remmen, insulin resistance, loss, muscle, newsok, OKC, oklahama city, Oklahoma Medical Research Foundation, OMRF, option, parkinsons, redox biology, rizwan qaisar, sarcopenia, scientist-news, therapeutic, treatment, van remmen

OMRF receives $2.8 million grant to study rare disorder

August 23, 2018

The grant will provide Bob Axtell with $2.8 million to study NMO and investigate its similarities to other autoimmune diseases, particularly MS.

Filed Under: News Tagged With: allergy, approved, autoimmune, Axtell, Bob Axtell, brain stem, consequences, develop, disease, infectious diseases, interferon, interferon beta, lupus, multiple sclerosis, National Institutes of Health, neuromyelitis optica, new, news, newsok, NIAID, NIH, NMO, OKC, Oklahoma Medical Research Foundation, OMRF, option, robert, Robert Axtell, scientist-news, therapy, treatment

New hope in the fight against sickle cell disease

June 14, 2018

For Mary Long, the answer to her pain may, literally, be right around the corner.

Filed Under: News Tagged With: biology, biotechnology, blood, cell, disease, drug, mary long, McEver, news, newsok, novartis, OKC, Oklahoma Medical Research Foundation, OMRF, option, P-selectin, pain, patients, rodger, Rodger McEver, scd, scientist-news, selexys, sickle cell, therapy

Before Footer

EEO/AA Employer/Vet/Disabled

Footer

  • Jobs
  • Directory
  • Donor Privacy Statement
  • Intranet
Facebook Twitter Instagram Linkedin

Subscribe to OMRF News
  • Contact
  • Careers
  • Donor Privacy
  • Intranet
OMRF Logo
OKLAHOMA MEDICAL RESEARCH FOUNDATION
825 NE 13th St.
Oklahoma City, OK 73104
(405) 271-6673
Charity navigatorUnited WayGive Smart OKCTop Workplace